These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8481018)

  • 1. Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group.
    Goldberg LH; Kaufman R; Kurtz TO; Conant MA; Eron LJ; Batenhorst RL; Boone GS
    Arch Dermatol; 1993 May; 129(5):582-7. PubMed ID: 8481018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
    Baker DA
    J Int Med Res; 1994; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year suppression of frequent recurrences of genital herpes with oral acyclovir.
    Baker DA; Blythe JG; Kaufman R; Hale R; Portnoy J
    Obstet Gynecol; 1989 Jan; 73(1):84-7. PubMed ID: 2642329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
    Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
    Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection.
    Mertz GJ; Eron L; Kaufman R; Goldberg L; Raab B; Conant M; Mills J; Kurtz T; Davis LG
    Am J Med; 1988 Aug; 85(2A):14-9. PubMed ID: 3044076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study.
    Kroon S; Petersen CS; Andersen LP; Rasmussen LP; Vestergaard BF
    Dan Med Bull; 1989 Jun; 36(3):298-300. PubMed ID: 2666040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.
    Straus SE; Takiff HE; Seidlin M; Bachrach S; Lininger L; DiGiovanna JJ; Western KA; Smith HA; Lehrman SN; Creagh-Kirk T
    N Engl J Med; 1984 Jun; 310(24):1545-50. PubMed ID: 6328297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of recurrent genital herpes by single daily dosages of acyclovir.
    Mostow SR; Mayfield JL; Marr JJ; Drucker JL
    Am J Med; 1988 Aug; 85(2A):30-3. PubMed ID: 3044089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study.
    Halsos AM; Salo OP; Lassus A; Tjøtta EA; Hovi T; Gabrielsen BO; Fiddian AP
    Acta Derm Venereol; 1985; 65(1):59-63. PubMed ID: 2578707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir.
    Fife KH; Almekinder J; Ofner S
    Sex Transm Dis; 2007 May; 34(5):297-301. PubMed ID: 16960547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.
    Molin L; Ruhnek-Forsbeck M; Svennerholm B
    Scand J Infect Dis Suppl; 1991; 80():33-9. PubMed ID: 1666444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oral acyclovir in the management of genital herpes simplex.
    Sacks SL
    CMAJ; 1987 Apr; 136(7):701-7. PubMed ID: 3548933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group.
    Kaplowitz LG; Baker D; Gelb L; Blythe J; Hale R; Frost P; Crumpacker C; Rabinovich S; Peacock JE; Herndon J
    JAMA; 1991 Feb; 265(6):747-51. PubMed ID: 1990191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.
    Mertz GJ; Jones CC; Mills J; Fife KH; Lemon SM; Stapleton JT; Hill EL; Davis LG
    JAMA; 1988 Jul; 260(2):201-6. PubMed ID: 3290517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
    Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.